Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
102364 trials found · Page 172 of 5119
-
New triple therapy aims to wipe out esophageal tumors before surgery
Disease control Not yet recruitingThis is a single-arm, exploratory clinical study.
Phase: PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 08, 2026 13:12 UTC
-
New pill aims to keep narcolepsy patients awake and Fall-Free
Symptom relief Recruiting nowThe purpose of this study is to measure decreases in daytime sleepiness, cataplexy (sudden loss of muscle tone), and disease symptoms in participants with NT1 when taking ALKS 2680 tablets compared with placebo tablets.
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Jun 08, 2026 13:12 UTC
-
Stem cell gel may speed burn healing in new trial
Disease control Recruiting nowTo evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells combined with bovine type I collagen in the treatment of third-degree burn wounds.
Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 02, 2026 11:57 UTC
-
New pill aims to slow lung scarring in IPF patients
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of HSK44459 tablets in patients with idiopathic pulmonary fibrosis (IPF).
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
New pill aims to slow lung scarring in progressive pulmonary fibrosis
Disease control Not yet recruitingThis study is open to adults with PPF . The main objective is to evaluate of the efficacy and the secondary objective is to evaluate the safety and pharmacokinetic.
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC
-
Viruses vs. superbugs: new hope for implant infections?
Disease control Not yet recruitingA Prospective, Single-Center, Single-Arm Clinical Study with a Pre-Post Self-Controlled Design Evaluating the Efficacy and Safety of Bacteriophage Therapy for Refractory Orthopedic Implant-Associated Infections
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 10, 2026 11:41 UTC
-
New study aims to spare breast cancer patients from Heart-Damaging chemo
Disease control Not yet recruitingIparomlimab and Tuvonralimab Injection (QL1706) is a bifunctional combination antibody targeting both programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte antigen 4 (CTLA-4). This is a prospective clinical study that plans to enroll screened, eligible early-stage bre…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 05, 2026 12:06 UTC
-
New drug cocktail aims to shrink stomach tumors before surgery
Disease control Not yet recruitingThis study is a multicenter, randomized, two-cohort clinical trial to evaluate the efficacy and safety of SHR-1701 with or without apatinib in combined with chemotherapy of neoadjuvant treatment for resectable locally advanced gastric or gastroesophageal junction adenocarcinoma.
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 08, 2026 13:16 UTC
-
New hope for AF patients: needle-based stroke prevention without daily pills
Disease control Recruiting nowThis study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. When this happens, blood cannot move smoothly through…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 29, 2026 14:17 UTC
-
New drug salanersen aims to boost motor function in SMA patients
Disease control Recruiting nowIn this study, researchers will learn more about the effects and safety of BIIB115, also known as salanersen. Specifically, researchers will learn more about how salanersen works in individuals with SMA who are between the ages of 15 and 60 years old. In most people living with …
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 05, 2026 12:05 UTC
-
Tiny particles packed with steroids could restore hearing
Disease control Recruiting nowPrimary Objective To compare the efficacy of a single course of IT Exo-Dex versus conventional IT dexamethasone and exosome vehicle alone, as measured by the mean change in pure-tone average (PTA; 0.5, 1, 2, 4 kHz) from baseline to the 4-week post-treatment endpoint. Secondary O…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC
-
New hope for ovarian cancer: targeted drug combo aims to extend remission
Disease control Recruiting nowThis Phase 3 study will be conducted in different countries around the world with up to about 528 participants. The purpose of this study is to evaluate how well Rina-S works against ovarian cancer in combination with available standard of care therapy that is already approved a…
Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC
-
New combo therapy aims to stop prostate cancer spread in its tracks
Disease control Recruiting nowThe advent of PSMA-PET has improved sensitivity and specificity in staging prostate cancer, particularly in intermediate- and high-risk disease. This has created uncertainty in the management of patients with PSMA-positive but conventionally negative pelvic lymphadenopathy (i.e.,…
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
New drug targets hard-to-treat lung cancer in early trial
Disease control Recruiting nowThe aim of the study to evaluate the safety and efficacy of SKB571 for injection as monotherapy in patients with locally advanced or metastatic Non-Small Cell Lung Cancer with MET abnormalities. Eligible subjects will receive SKB571 monotherapy, until radiographic disease progres…
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:06 UTC
-
New lupus drug candidate enters Mid-Stage trial
Disease control Recruiting nowThis study is a randomized, double-blind, multi-center, placebo-controlled Phase II clinical trial to evaluate the efficacy and safety of SHR-2173 in adult participants with active Systemic Lupus Erythematosus (SLE), including a 4-week screening period, a 24-week core treatment p…
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 05, 2026 12:05 UTC
-
Gut bacteria therapy shows promise for ulcerative colitis in new trial
Disease control Recruiting nowThe main goal of the study is to check if MH002 works and is safe to use. In a previous study in 45 patients with Ulcerative Colitis, MH002 was found to have favorable effects. In this study, 2 different doses will be tested, and long-term treatment effects will be investigated. …
Phase: PHASE2 • Sponsor: MRM Health NV • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC
-
Could a pill stop Alzheimer's before it starts? new trial targets gene carriers
Prevention Not yet recruitingPrimary Objectives: To demonstrate that HT-4253 improves the amyloid risk profile by transitioning biomarker-positive APOE4 carriers from a positive, high risk APS2 score to a negative, low risk APS2 score. Secondary Objectives: * To assess the effects of HT-4253 on tau relate…
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Prevention
Last updated Jun 09, 2026 12:09 UTC
-
New lung cancer drug combo faces off against standard treatment in major trial
Disease control Recruiting nowThis study aims to evaluate the efficacy and safety of RC148 combined with platinum-based chemotherapy versus Tislelizumab combined with platinum-based chemotherapy in participants with locally advanced or metastatic Squamous NSCLC who have not received first-line treatment. Part…
Phase: PHASE3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC
-
Could a common antibiotic help the brain heal after a stroke?
Disease control Recruiting nowThis is a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. It aims to evaluate the efficacy and safety of oral minocycline in patients with acute spontaneous intracerebral hemorrhage within 48 hours of onset.
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 10, 2026 11:41 UTC
-
Double-barreled CAR-T takes aim at hard-to-treat blood cancers
Disease control Not yet recruitingThis is a single arm study to evaluate the safety and efficacy of CAR19BCMA CAR-T cells in the treatment of relapsed/refractory CD19/BCMA positive plasma cell neoplasms and lymphomas/leukemias with plasmacytic differentiation.
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC